Cargando…

FRI638 Glycemic And Cost Outcomes In Hispanic/Latino People With Type 2 Diabetes Initiating Dulaglutide Or Basal Insulin In The US

Disclosure: M. Hoog: Employee; Self; Eli Lilly & Company. Stock Owner; Self; Eli Lilly & Company. J. Maldonado: Employee; Self; Eli Lilly & Company. Stock Owner; Self; Eli Lilly & Company. R. Wangia-Dixon: Employee; Self; Optum Inc. Other; Self; Eli Lilly & Company. R. Halpern: E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoog, Meredith, Maldonado, Juan, Wangia-Dixon, Ruth, Halpern, Rachel, Buysman, Erin, Gremel, Garrett, Huang, Ahong, Konig, Manige
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Diabetes And Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555009/ http://dx.doi.org/10.1210/jendso/bvad114.857

Ejemplares similares

LBSUN319 Characteristics And Treatment Patterns Of Hispanic/latino Patients Initiating First Injectable Glp-1ra Or Basal Insulin
por: Hoog, Meredith, et al.
Publicado: (2022)

Glycemic and Economic Outcomes in Elderly Patients with Type 2 Diabetes Initiating Dulaglutide Versus Basal Insulin in a Real-World Setting in the United States: The DISPEL-Advance Study
por: Hoog, Meredith, et al.
Publicado: (2023)

FRI646 Dulaglutide-induced Acute Liver Injury - A Case Report
por: Shahid, Maham, et al.
Publicado: (2023)

OR30-06 Assessment of Dulaglutide Safety in Older Patient Populations in Rewind
por: Konig, Manige, et al.
Publicado: (2020)

MON-638 The WBC Differential in Relation to DKA Severity
por: Alamri, Bader Nasser, et al.
Publicado: (2020)

Variations of dietary intake by glycemic status and Hispanic/Latino heritage in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
por: Casagrande, Sarah S, et al.
Publicado: (2018)

Necrotizing Pancreatitis Secondary to Dulaglutide Use
por: Bhat, Salman Zahoor, et al.
Publicado: (2021)

SUN-638 Perinatal DDE Exposure Disrupts Thermogenesis Early in Development
por: vonderEmbse, Annalise, et al.
Publicado: (2020)

FRI659 Diabetes Management: A Retrospective Population-based Study Examining The Association Of Acculturation And Glycemic Control
por: Lee Messersmith, Andrew, et al.
Publicado: (2023)

OR28-4 Efficacy and Safety of Tirzepatide Versus Semaglutide in a Hispanic or Latino Population: A Prespecified Subgroup Analysis of SURPASS-2
por: Benneyworth, Brian D, et al.
Publicado: (2022)

FRI655 Impact Of Digital Twin Intervention On Visceral Fat And Glycemic Control In T2dm With Different Levels Of Visceral Fat
por: Rameshchandra Joshi, Shashank, et al.
Publicado: (2023)

FRI606 Changes In The Pedal Microcirculation Of Diabetic Patients With Poor Glycemic Control Detected Using Non Invasive Optical Imaging
por: Kendra Bolakale-Rufai, Ikeoluwapo, et al.
Publicado: (2023)

FRI652 Type 2 Diabetes Management: More GLP1 Agonists And Less Metformin?
por: Lopez Maldonado, Francisco J, et al.
Publicado: (2023)

Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis
por: Patel, Hiren, et al.
Publicado: (2019)

Comparing Quality of Life in Type 2 Diabetic Patients Using Dulaglutide and Liraglutide
por: Ghosh, Aneesh
Publicado: (2021)

Anaphylactic Reaction to Dulaglutide: A Glucagon Like Peptide- 1 Receptor Agonist
por: Quadri, Hamza, et al.
Publicado: (2021)

PSUN241 A Case of Dulaglutide-Induced Acute Pancreatitis in a Diabetic Patient – A Case Report
por: Abdelmasih, Randa, et al.
Publicado: (2022)

Managing Hispanic and Latino Employees
por: Nevaer, Louis
Publicado: (2010)

Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
por: Robinson, Susan, et al.
Publicado: (2020)

HbA(1c) Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial
por: Kwan, Anita Y.M., et al.
Publicado: (2022)

FRI637 Missed MODY With Complex Mutation
por: Bulchandani, Sheetal, et al.
Publicado: (2023)

Prevalence, Awareness, and Treatment of Hypertension in Hispanics/Latinos With CKD in the Hispanic Community Health Study/Study of Latinos
por: Lora, Claudia M., et al.
Publicado: (2020)

Periodontal Disease and Incident CKD in US Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos
por: Toth-Manikowski, Stephanie M., et al.
Publicado: (2021)

SAT-638 An Academic Center Experience with the Eversense Continuous Glucose Monitoring System and Assessment of Intrapatient Variability with Repeated Same-Pocket Insertion
por: Lee, Warren, et al.
Publicado: (2020)

PSUN270 Magnified Risk of Pancreatitis by GLP-1: A Case of Necrotizing Pancreatitis in a Patient on Dulaglutide with Baseline Elevated Triglycerides
por: Yau, Alice, et al.
Publicado: (2022)

Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND
por: Konig, Manige, et al.
Publicado: (2021)

MON-681 Dulaglutide Commonly Known as Trulicity; An Anti-Diabetic Medication Causing Small Bowel Obstruction
por: Gandhi, Ankita, et al.
Publicado: (2020)

Prevalence of Metabolic Syndrome Among Hispanics/Latinos of Diverse Background: The Hispanic Community Health Study/Study of Latinos
por: Heiss, Gerardo, et al.
Publicado: (2014)

Is Acculturation Related to Obesity in Hispanic/Latino Adults? Results from the Hispanic Community Health Study/Study of Latinos
por: Isasi, Carmen R., et al.
Publicado: (2015)

Incidence of Hypertension Among US Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos, 2008 to 2017
por: Elfassy, Tali, et al.
Publicado: (2020)

Polygenic risk scores and kidney traits in the Hispanic/Latino population: The Hispanic Community Health Study/Study of Latinos
por: Zhou, Laura Y., et al.
Publicado: (2023)

Adherence and persistence among patients with type 2 diabetes initiating dulaglutide compared with semaglutide and exenatide BCise: 6‐month follow‐up from US real‐world data
por: Mody, Reema, et al.
Publicado: (2020)

FRI604 Stem-cell Derived Islets For Treating Diabetes
por: Rust, William L, et al.
Publicado: (2023)

FRI617 Targeting Unc119b For Insulin Sensitization
por: Mittal, Ayushi, et al.
Publicado: (2023)

FRI618 Lifetime Risk Of Nontraumatic Lower-extremity Amputation
por: Ding, Ning, et al.
Publicado: (2023)

FRI664 The Impact Of Prediabetes Diagnosis On The Prevalence Of Postbariatric Hypoglycemia
por: Reshma Shariff, Julia Rose, et al.
Publicado: (2023)

Efficacy of Dulaglutide Expanded Doses by Baseline A1C Categories: Post Hoc Analysis of AWARD-11
por: Frias, Juan Pablo, et al.
Publicado: (2021)

PSUN148 Disparities in COVID-19 Mortality in Hispanic and Non-Hispanic Patients with Metabolic Syndrome in a Community-Based Hospital
por: Ho, Erwin, et al.
Publicado: (2022)

Association of diabetes with tooth loss in Hispanic/Latino adults: findings from the Hispanic Community Health Study/Study of Latinos
por: Greenblatt, Ariel P, et al.
Publicado: (2016)

The effect of Dulaglutide on glycemic and weight control in patients with type 2 diabetes
por: Ruda, Alexandru Ioan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qhhk8torrtuleo11lp59cuabii